According to a new report, published by KBV research, The Global Opioids Market size is expected to reach $5.4 billion by 2027, rising at a market growth of 3.5% CAGR during the forecast period.
The Pain Management segment acquired maximum revenue share in the Global Opioids Market by Application in 2020, thereby, achieving a market value of $3.1 billion by 2027. Due to the rapid increase in the number of patients suffering from chronic headaches, migraines, and backaches; patients recovering from surgery or experiencing severe pain associated with cancer; and individuals injured during sports activities, traffic collisions, or other incidents, this segment is expected to grow at a significant rate.
The Oxycodone segment is showcasing a CAGR of 2.6% during (2021 - 2027). Oxycodone extended-release pills and capsules are prescribed to treat severe pain in patients who need pain medication around the clock for an extended period of time and who do not respond to other treatments. Oxycodone extended-release tablets, extended-release capsules, and concentrated solution is ideally only to be used to treat persons who have been exposed to opioid drugs for at least one week and have become accustomed to its effects.
The Asia Pacific market dominated the Global Opioids Market by Region in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1.4 billion by 2027. The Europe market is estimated to witness a CAGR of 3.3% during (2021 - 2027). Additionally, The North America market would experience a CAGR of 3.2% during (2021 - 2027).
Full Report: https://www.kbvresearch.com/opioids-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
By Application
By Product Type
By Geography
Companies Profiled
Unique Offerings 
